Optiscan Imaging
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 1 Dec 2025
- Reported shorts
- 12.5K
- Shares on issue
- 1.044B
Optiscan Imaging (OIL) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $448.8Kvs $951.9K (FY25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$7.0Mvs −$6.3M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.007T (source: Derived: trailing 12 months at year end)vs −$0.008 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- −52.9%FY
- EPS YoY
- n/aFY
- Derived: trailing 12 months at year end
Summary of Preliminary Final Report, 25 Aug 2026
Optiscan Imaging's FY26 revenue fell 52.9% to $448,769, while its net loss widened 10.7% to $6,986,043. No dividend was paid or declared. The company attributed the revenue decline to lower orders from Carl Zeiss Meditec and reduced ViewnVivo sales, and noted increased investment in R&D and commercial activities.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026
- Gross margin
- 41.5%
- Operating margin
- −2,362.7%
- Net margin
- −1,556.7%
- FCF margin
- −1,640.0%
- ROE
- −52.4%
- ROA
- −42.9%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $14.3M
- Net debt / EBITDA
- n/a
- Current ratio
- 10.8×
- Interest cover
- −130.0×
- Cash dividends paid / net profit
- n/a
- Market cap
- $161.8M
- P/E
- n/a
- P/B
- 8.5×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $448.8K | $951.9K | $1.2M | $1.7M |
| Gross profit | $186.4K | $479.9K | $629.4K | $1.1M |
| Operating income | −$10.6M | −$9.4M | −$8.4M | −$5.3M |
| EBITDA | −$6.6M | −$5.8M | −$5.5M | −$3.9M |
| EBIT | −$6.9M | −$6.3M | −$6.0M | −$4.3M |
| Interest expense | $81.5K | $25.8K | $23.7K | $32.3K |
| Pretax income | −$7.0M | −$6.3M | −$6.1M | −$4.4M |
| Tax | $12.6K | $20.3K | $0 | $0 |
| NPAT | −$7.0M | −$6.3M | −$6.1M | −$4.4M |
| Net interest income | $464.9K | $308.8K | $523.9K | −$1.2K |
| EPS basic | −$0.007T (source: Derived: trailing 12 months at year end) | −$0.008 | −$0.007 | −$0.007 |
| EPS diluted | −$0.007T (source: Derived: trailing 12 months at year end) | −$0.008 | −$0.007 | −$0.007 |
| Shares | 1.04B | 841.1M | 835.3M | 630.6M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- 2026 Annual ReportAnnual Report25 Aug 2026via asx_announcements
- Preliminary Final ReportAnnual Results25 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4DHalf Year Results25 Feb 2026via asx_announcements
- Half Year Report - 31 December 2025Half Year Results25 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Oct 2025via asx_announcements
- 2025 Annual ReportAnnual Report29 Aug 2025via asx_announcements
- Appendix 4E - Preliminary Final ReportAnnual Results29 Aug 2025via asx_announcements
Showing 10 of 24 reports